<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CAPPOLINO DODD &#38; KREBS LLP</title>
	<atom:link href="http://www.defectivedrugslaw.com/feed" rel="self" type="application/rss+xml" />
	<link>http://www.defectivedrugslaw.com</link>
	<description></description>
	<lastBuildDate>Wed, 28 Mar 2012 19:11:27 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Recent Birth Control Pill Recalls</title>
		<link>http://www.defectivedrugslaw.com/recent-birth-control-pill-recalls</link>
		<comments>http://www.defectivedrugslaw.com/recent-birth-control-pill-recalls#comments</comments>
		<pubDate>Mon, 26 Mar 2012 20:33:52 +0000</pubDate>
		<dc:creator>Jeremy</dc:creator>
				<category><![CDATA[Newletters]]></category>
		<category><![CDATA[dangerous drug]]></category>
		<category><![CDATA[drug attorney]]></category>
		<category><![CDATA[drug lawyer]]></category>
		<category><![CDATA[drug recall]]></category>
		<category><![CDATA[recalled drug]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=939</guid>
		<description><![CDATA[On Jan. 31, Pfizer Inc. recalled 1 million packets of birth control pills, including 14 lots of Lo/Ovral-28 and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. The pills were recalled because of packaging errors that resulted in some packets having too many active pills and some packets having too few. Each birth control packet contains three weeks of active hormone pills and one week of inactive sugar pills. Missing two or more active tablets in a row can render that cycle of birth control pills ineffective. As such, the packages with inadequate dosing put women at risk of accidental pregnancy. A Pfizer spokesperson attributed the problem to mechanical and visual inspection errors and said the issue has been corrected. Following the Pfizer incident, Glenmark Generics Inc. issued a drug recall on Feb. 24 for seven lots of its Norgestimate and Ethinyl Estradiol tablets. Each package includes a blister...<br /> <a href="http://www.defectivedrugslaw.com/recent-birth-control-pill-recalls">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/recent-birth-control-pill-recalls/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ignoring the Law: When Pharmaceutical Companies Promote a Drug’s Off-Label Uses</title>
		<link>http://www.defectivedrugslaw.com/ignoring-the-law-when-pharmaceutical-companies-promote-a-drug%e2%80%99s-off-label-uses</link>
		<comments>http://www.defectivedrugslaw.com/ignoring-the-law-when-pharmaceutical-companies-promote-a-drug%e2%80%99s-off-label-uses#comments</comments>
		<pubDate>Thu, 23 Feb 2012 16:33:58 +0000</pubDate>
		<dc:creator>Jeremy</dc:creator>
				<category><![CDATA[Newletters]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=857</guid>
		<description><![CDATA[The increased risk for birth defects associated with Depakote (discussed here) is not the only reason this dangerous drug has recently made headlines. Abbott Laboratories, the maker of Depakote, has gotten into hot water over allegations it illegally promoted the drug&#8217;s off-label use. Thomas Spetter, Jr. filed a whistleblower lawsuit alleging that a sales rep at Abbott told him and other trainees to ignore the corporate trainers&#8217; directions about only marketing drugs for approved purposes and to instead market the epilepsy drug Depakote as a treatment of dementia-related agitation, a non-approved use. Spetter&#8217;s lawsuit, along with suits filed by three other groups of whistleblowers, has prompted the Justice Department to investigate whether Abbott violated any civil or criminal laws in promoting Depakote, specifically, whether the company engaged in off-label marketing. Abbott announced in October 2011 that it was setting aside $1.5 billion for settling the allegations. Off-label use refers to...<br /> <a href="http://www.defectivedrugslaw.com/ignoring-the-law-when-pharmaceutical-companies-promote-a-drug%e2%80%99s-off-label-uses">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/ignoring-the-law-when-pharmaceutical-companies-promote-a-drug%e2%80%99s-off-label-uses/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>28 Lots of Birth Control Pills Recalled by Pfizer</title>
		<link>http://www.defectivedrugslaw.com/28-lots-of-birth-control-pills-recalled-by-pfizer</link>
		<comments>http://www.defectivedrugslaw.com/28-lots-of-birth-control-pills-recalled-by-pfizer#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:42:51 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=824</guid>
		<description><![CDATA[Pfizer is recalling fourteen lots of Lo/Ovral and fourteen lots of generic Norgestrel &#38; Ethinyl Estradiol tablets.  This number equals 1 million packets of birth control pills. The basis of the recall is that the hormones were manufactured with inadequate levels of hormones, which increases the risk of pregnancy.  Some packages had too many active tablets, while others had too few. According to a Pfizer spokeswoman, the problem was caused by mechanical and visual inspection failures as well as failures on the packaging line. &#160;]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/28-lots-of-birth-control-pills-recalled-by-pfizer/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Johnson &amp; Johnson Sued Again Over Risperdal</title>
		<link>http://www.defectivedrugslaw.com/johnson-johnson-sued-again-over-risperdal</link>
		<comments>http://www.defectivedrugslaw.com/johnson-johnson-sued-again-over-risperdal#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:41:39 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=808</guid>
		<description><![CDATA[On January 9 trial began for Johnson &#38; Johnson Inc. and its subsidiary Janssen Pharmaceutical LLC, along with five other related companies which are accused of having defrauded the state in a “sophisticated marketing scheme” that caused the Texas Medicaid program to pay too much for the schizophrenia drug Risperdal.  The State is also alleging that the company misled state health officials about the drug’s effectiveness. About six years ago, Texas became involved with Risperdal litigation together with corporate whistleblower Allen Jones.  The issue surrounding that litigation was questioning of how Risperdal was approved in Texas, then how that information was used by other states in their approval processes.  According to the Statesman, Texas claims that the drug companies prevented state health officials from receiving “truthful information about the safety, efficacy, appropriate uses and cost-effectiveness of Risperdal”.  The lawsuit also alleges that lawmakers and doctors have received kickbacks to give...<br /> <a href="http://www.defectivedrugslaw.com/johnson-johnson-sued-again-over-risperdal">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/johnson-johnson-sued-again-over-risperdal/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Risperdal Overrated?</title>
		<link>http://www.defectivedrugslaw.com/is-risperdal-overrated</link>
		<comments>http://www.defectivedrugslaw.com/is-risperdal-overrated#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:41:14 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=805</guid>
		<description><![CDATA[Risperdal (also known as Risperidone) is an antipsychotic medication used to treat various mental illnesses.  Schizophrenic symptoms are often relieved with Risperdal.  It is also used to treat mania (frenzied, abnormally excited, or irritated mood) in adults and children over 10 years of age.  Lastly, Resperdal is prescribed to treat behavior problems such as aggression, self-injury and sudden mood changes in teenagers and children 5-16 years of age who have autism. Although Risperdal was only FDA approved for treatment of schizophrenia, bipolar and autism symptoms, doctors have been prescribing Risperdal “off label” for the treatment of anxiety disorders, such as obsessive compulsive disorder, severe depression, tourette’s syndrome, disruptive behavior disorders in children; and eating disorders.  Over ten million people worldwide have been prescribed Risperdal. Some doctors and consumer groups worry that patients are being subjected to unnecessary risks due to a wider range of conditions being treated with Risperdal.  The...<br /> <a href="http://www.defectivedrugslaw.com/is-risperdal-overrated">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/is-risperdal-overrated/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zoloft Risky For Expectant Mothers</title>
		<link>http://www.defectivedrugslaw.com/zoloft-risky-for-expectant-mothers</link>
		<comments>http://www.defectivedrugslaw.com/zoloft-risky-for-expectant-mothers#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:40:21 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=803</guid>
		<description><![CDATA[Zoloft is an antidepressant prescribed to treat patients with depression and generalized anxiety disorder.  However, this drug has precautions.  The FDA has issued two major alerts concerning injuries caused by Zoloft. Zoloft has been known to cause persistent pulmonary hypertension (PPHT) in babies whose mothers used the drug during pregnancy.  Babies with PPHT have an inadequate blood supply to the lungs which causes oxygen depleted blood to return to the heart.  Although some infants can recover quickly, others can have complications and require care throughout the rest of their lives.  Statistics show that if the mother was on Zoloft while pregnant they are six times more likely to have a child with a birth defect. Zoloft is also a cause of serotonin syndrome.  Serotonin controls moods, emotions, sleep cycles and appetite.  Some drugs like Zoloft can contribute to having too high of levels of serotonin in your body.  Serotonin syndrome...<br /> <a href="http://www.defectivedrugslaw.com/zoloft-risky-for-expectant-mothers">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/zoloft-risky-for-expectant-mothers/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fosamax Tied To Femur Fractures</title>
		<link>http://www.defectivedrugslaw.com/fosamax-tied-to-femur-fractures</link>
		<comments>http://www.defectivedrugslaw.com/fosamax-tied-to-femur-fractures#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:39:41 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=787</guid>
		<description><![CDATA[Fosamax is used to prevent and treat osteoporosis in women who are past menopause.  Fosamax has been linked to osteonecrosis of the jaw (ONJ), a rare condition in which the jawbone in the mouth dies.  ONJ is commonly referred to as “dead jaw”.  The typical signs and symptoms of osteonecrosis of the jaw may include pain, swelling or infection of the gums, loosening of the teeth, poor healing of the gums, numbness or a feeling of heaviness in the jaw, drainage and exposed bone. In the most serious cases, some patients may require the removal of sections of the jaw. Now, Fosamax has also been linked to a rare type of leg fracture that cuts straight across the upper thigh bone after little or no trauma.  Patients reported that, after weeks or months of unexplained aching, their thighbones simply snapped while they were walking or standing.  A recent series of...<br /> <a href="http://www.defectivedrugslaw.com/fosamax-tied-to-femur-fractures">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/fosamax-tied-to-femur-fractures/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Topamax Linked to Cleft Palate, Other Birth Defects</title>
		<link>http://www.defectivedrugslaw.com/topamax-linked-to-cleft-palate-other-birth-defects</link>
		<comments>http://www.defectivedrugslaw.com/topamax-linked-to-cleft-palate-other-birth-defects#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:38:54 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=774</guid>
		<description><![CDATA[In March of 2011, the FDA graded Topamax as a Category D medication, in other words a drug that shows positive evidence of human fetal risk. When taken during pregnancy, Topamax, originally prescribed to treat migraine headaches and epilepsy, has been shown to increase the risk of birth defects and oral deformities in the developing fetus. Specific birth defects that have been linked to Topamax are:  cleft palate, cleft lip, fetal and skeletal malformations and hypospadias (malformation of the urethra in boys). A cleft palate or lip occurs when the mouth fails to fully form, causing a split or gap in the roof of the mouth.  These deformities may cause developmental issues and can lead to severe ear infections and problems with eating and talking. Topamax has also been prescribed “off label” for conditions such as:  bipolar disorder, post traumatic stress disorder, infantile spasms, bulimia, obsessive compulsive disorder, obesity and...<br /> <a href="http://www.defectivedrugslaw.com/topamax-linked-to-cleft-palate-other-birth-defects">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/topamax-linked-to-cleft-palate-other-birth-defects/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Court Settles Motrin Case</title>
		<link>http://www.defectivedrugslaw.com/court-settles-motrin-case</link>
		<comments>http://www.defectivedrugslaw.com/court-settles-motrin-case#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:38:06 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=771</guid>
		<description><![CDATA[In October 2011 a Los Angeles jury returned a record setting verdict against Johnson &#38; Johnson and the McNeil Consumer Healthcare companies.  The verdict was given for $48.2 million.  After interest and cost of judgment is included the figure could reach nearly $60 million. The lawsuit brought forth by Christopher Trejo (now 22) and his attorneys alleged that Motrin had causes Stevens Johnson Syndrome (SJS) and in its later stages Toxic Epidermal Necrolysis (TEN) in Trejo.  Both SJS and TEN are serious and potentially fatal diseases that cause large areas of the skin to become detached and lesions to develop in the mucous membranes. At 16 years of age, Trejo had taken Motrin as directed on the label for less then one week, but was stricken with TEN.  It caused severe inside-out exfoliating reaction to his mucosal membranes, severe pulmonary damage, near blindness, infertility, whole body scarring and hypoxic brain...<br /> <a href="http://www.defectivedrugslaw.com/court-settles-motrin-case">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/court-settles-motrin-case/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stevens Johnson Syndrome Repeatedly Misdiagnosed</title>
		<link>http://www.defectivedrugslaw.com/stevens-johnson-syndrome-repeatedly-misdiagnosed</link>
		<comments>http://www.defectivedrugslaw.com/stevens-johnson-syndrome-repeatedly-misdiagnosed#comments</comments>
		<pubDate>Thu, 02 Feb 2012 18:46:09 +0000</pubDate>
		<dc:creator>karina</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.defectivedrugslaw.com/?p=810</guid>
		<description><![CDATA[For patients dealing with Stevens Johnson Syndrome, getting appropriately diagnosed can often be difficult.  Often doctors misread the symptoms and diagnose a less serious condition.  If patients are not aware that SJS is one of the reported Dilantin side effects (or a possible side effect from another medication) they may not think to tell their doctors that Dilantin could be the cause of their symptoms. With SJS, a quick, accurate diagnosis is pertinent to survival.  SJS is a painful, life threatening condition that begins as an allergic reaction to a medication.  It can begin at any time.  Additionally, a patient can react to a medication that he has previously taken with no side effects.  Many times doctors administer second and third doses of the medication that the patient is reacting to due to an inaccurate diagnosis. SJS starts off with flaky skin and a painful rash, then quickly turns into...<br /> <a href="http://www.defectivedrugslaw.com/stevens-johnson-syndrome-repeatedly-misdiagnosed">Read More &#187;</a>]]></description>
		<wfw:commentRss>http://www.defectivedrugslaw.com/stevens-johnson-syndrome-repeatedly-misdiagnosed/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

